SAN DIEGO, CA
| Filer | Form | Target | Filed | Activity | |
|---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LPCIK · 1103804 | 13F-HR Holdings | — | Aug 14, 2026 Aug 14, 2026 | — | |
REDMILE GROUP, LLCCIK · 1425738 | 13F-HR Holdings | — | Aug 14, 2026 Aug 14, 2026 | — | |
ROYSTON AARONCIK · 1727703 | 4 Trade | ACHIEVE LIFE SCIENCES, INC.CIK · 949858 | Jul 29, 2026 Jul 29, 2026 | 2txn | |
REDMILE GROUP, LLCCIK · 1425738 | 4 Trade | ATARA BIOTHERAPEUTICS, INC.CIK · 1604464 | Jul 25, 2026 Jul 25, 2026 | 7txn | |
KUSH ARVINDCIK · 1986806 | 4 Trade | INHIBIKASE THERAPEUTICS, INC.CIK · 1750149 | Jun 30, 2026 Jun 30, 2026 | 1txn | |
LARSON YICIK · 1785987 | 4 Trade | OLEMA PHARMACEUTICALS, INC.CIK · 1750284 | Jun 23, 2026 Jun 23, 2026 | 1txn | |
REDMILE GROUP, LLCCIK · 1425738 | 4 Trade | FATE THERAPEUTICS INCCIK · 1434316 | Jun 15, 2026 Jun 15, 2026 | 1txn | |
VAN HAUWERMEIREN TIMOTHYCIK · 1816206 | 4 Trade | DENALI THERAPEUTICS INC.CIK · 1714899 | Jun 5, 2026 Jun 5, 2026 | 2txn | |
MORAN SUSANCIK · 1835225 | 4 Trade | CRESCENT BIOPHARMA, INC.CIK · 1253689 | Jun 3, 2026 Jun 3, 2026 | 1txn | |
REDMILE GROUP, LLCCIK · 1425738 | 13F-HR Holdings | — | May 15, 2026 May 15, 2026 | — | |
VIKING GLOBAL INVESTORS LPCIK · 1103804 | 13F-HR Holdings | — | May 15, 2026 May 15, 2026 | — | |
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) II L.P.CIK · 1903360 | 4 Trade | AVALYN PHARMA INC.CIK · 1540171 | May 1, 2026 May 1, 2026 | 3txn | |
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) II L.P.CIK · 1903360 | 3 Initial | AVALYN PHARMA INC.CIK · 1540171 | Apr 30, 2026 Apr 30, 2026 | 2txn | |
ROYSTON AARONCIK · 1727703 | 3 Initial | ACHIEVE LIFE SCIENCES, INC.CIK · 949858 | Apr 27, 2026 Apr 27, 2026 | 1txn | |
OLIGER CHRISTY J.CIK · 1822092 | 4 Trade | REPLIMUNE GROUP, INC.CIK · 1737953 | Apr 8, 2026 Apr 8, 2026 | 1txn | |
REDMILE GROUP, LLCCIK · 1425738 | 13F-HR Holdings | — | Feb 17, 2026 Feb 17, 2026 | — | |
VIKING GLOBAL INVESTORS LPCIK · 1103804 | 13F-HR Holdings | — | Feb 17, 2026 Feb 17, 2026 | — | |
HEYMAN RICHARD A.CIK · 1584759 | 4 Trade | ORIC PHARMACEUTICALS, INC.CIK · 1796280 | Jan 20, 2026 Jan 20, 2026 | 2txn | |
HEYMAN RICHARD A.CIK · 1584759 | 144 Sale | ORIC PHARMACEUTICALS, INC.CIK · 1796280 | Jan 16, 2026 Jan 16, 2026 | — | |
HEYMAN RICHARD A.CIK · 1584759 | 144 Sale | ORIC PHARMACEUTICALS, INC.CIK · 1796280 | Jan 16, 2026 Jan 16, 2026 | — | |
HEYMAN RICHARD A.CIK · 1584759 | 4 Trade | ORIC PHARMACEUTICALS, INC.CIK · 1796280 | Jan 6, 2026 Jan 6, 2026 | 1txn | |
REDMILE GROUP, LLCCIK · 1425738 | 13F-HR Holdings | — | Nov 14, 2025 Nov 14, 2025 | — | |
VIKING GLOBAL INVESTORS LPCIK · 1103804 | 13F-HR Holdings | — | Nov 14, 2025 Nov 14, 2025 | — | |
VIKING GLOBAL INVESTORS LPCIK · 1103804 | 4 Trade | INHIBRX BIOSCIENCES, INC.CIK · 2007919 | Oct 9, 2025 Oct 9, 2025 | 3txn | |
HEYMAN RICHARD A.CIK · 1584759 | 4 Trade | ORIC PHARMACEUTICALS, INC.CIK · 1796280 | Oct 3, 2025 Oct 3, 2025 | 6txn |